ATE386016T1 - Harnstoffoligomere, deren zusammensetzungen und verfahren zur deren herstellung - Google Patents

Harnstoffoligomere, deren zusammensetzungen und verfahren zur deren herstellung

Info

Publication number
ATE386016T1
ATE386016T1 AT02785516T AT02785516T ATE386016T1 AT E386016 T1 ATE386016 T1 AT E386016T1 AT 02785516 T AT02785516 T AT 02785516T AT 02785516 T AT02785516 T AT 02785516T AT E386016 T1 ATE386016 T1 AT E386016T1
Authority
AT
Austria
Prior art keywords
group
compositions
production
aralkyl
alkynyl
Prior art date
Application number
AT02785516T
Other languages
English (en)
Inventor
Gilles Francois Roger Guichard
Jean-Paul Briand
Vincent Semetey
Patrick Neuberg
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE386016T1 publication Critical patent/ATE386016T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/20Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C275/24Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Steroid Compounds (AREA)
AT02785516T 2001-10-02 2002-10-02 Harnstoffoligomere, deren zusammensetzungen und verfahren zur deren herstellung ATE386016T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0112659A FR2830252B1 (fr) 2001-10-02 2001-10-02 Nouveaux oligomeres d'urees, leur procede de preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
ATE386016T1 true ATE386016T1 (de) 2008-03-15

Family

ID=8867837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02785516T ATE386016T1 (de) 2001-10-02 2002-10-02 Harnstoffoligomere, deren zusammensetzungen und verfahren zur deren herstellung

Country Status (10)

Country Link
US (2) US7691899B2 (de)
EP (1) EP1432677B1 (de)
JP (1) JP4621426B2 (de)
AT (1) ATE386016T1 (de)
CA (1) CA2462675C (de)
DE (1) DE60225031T2 (de)
DK (1) DK1432677T3 (de)
ES (1) ES2301691T3 (de)
FR (1) FR2830252B1 (de)
WO (1) WO2003029198A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006256439B2 (en) * 2005-03-18 2012-05-10 Centre National De La Recherche Scientifique New hybrid oligomers. Their preparation process and pharmaceutical compositions containing them
US20080033167A1 (en) * 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for synthesizing heterocyclic therapeutic compounds
CN105658670A (zh) 2013-08-21 2016-06-08 乌雷卡有限公司 肽-低聚尿素嵌合化合物及其使用方法
WO2016207726A1 (en) * 2015-06-22 2016-12-29 Ureka Sarl Bioinspired catalysis using oligourea helical foldamers
US10233213B2 (en) 2015-08-31 2019-03-19 Ureka Sarl Foldamer helix bundle-based molecular encapsulation
JP2019519478A (ja) 2016-04-19 2019-07-11 ユレカ・ソシエテ・ア・レスポンサビリテ・リミテUreka Sarl ペプチド−オリゴ尿素フォルダマー化合物及びそれらの使用方法
EP3911960A1 (de) 2019-01-18 2021-11-24 UREKA Sarl Peptid-oligoharnstoff-hybridverbindungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE254608C (de)
DD254319B1 (de) * 1986-12-08 1990-08-01 Fahlberg List Veb Biocide mittel auf der basis von derivaten des 2-brom-2-nitro-propan-1,3-diols
FR2788518B1 (fr) 1999-01-14 2001-03-02 Centre Nat Rech Scient Nouveaux carbamates actives stables, leur procede de preparation et leur utilisation pour la preparation d'urees

Also Published As

Publication number Publication date
DK1432677T3 (da) 2008-06-16
FR2830252B1 (fr) 2005-02-04
CA2462675A1 (fr) 2003-04-10
ES2301691T3 (es) 2008-07-01
US20100184849A1 (en) 2010-07-22
JP4621426B2 (ja) 2011-01-26
EP1432677A1 (de) 2004-06-30
US7691899B2 (en) 2010-04-06
CA2462675C (fr) 2013-08-27
EP1432677B1 (de) 2008-02-13
FR2830252A1 (fr) 2003-04-04
US20050038105A1 (en) 2005-02-17
JP2005504122A (ja) 2005-02-10
DE60225031T2 (de) 2009-07-02
WO2003029198A1 (fr) 2003-04-10
DE60225031D1 (de) 2008-03-27
US8071640B2 (en) 2011-12-06

Similar Documents

Publication Publication Date Title
BR9106819A (pt) Polimeros contendo unidades diester,processo para a preparacao de um polimero e compostos
BR0212277A (pt) Composto, processo para preparar um composto, uso de um composto, método para produzir um efeito inibidor do ibat, e, composição farmacêutica
DE60024830D1 (de) Verfahren zur herstellung heteroarylsubstituierter ureaverbindungen
CY1107403T1 (el) Μια μεθοδος δια την παρασκευη υπερινδοπριλης,των αναλογων ενωσεων αυτης και των αλατων αυτων με χρησιμοποιηση ενδιαμεσων ενωσεων 2,5-διοξο-οξαζολιδινης
BR0213802A (pt) Copolìmero útil para a preparação de géis de ácidos
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
AU2001292633A1 (en) Imidate-containing fluoropolymer compositions
WO2001081308A3 (en) Aminopiperidines for use as glyt-1 inhibitors
ATE218576T1 (de) Phosphohalohydrine, verfahren zu deren herstellung und verwendungen
DE50305141D1 (de) Verfahren zur herstellung von metallkomplexen
ATE424384T1 (de) Imidazolderivate, verfahren zu deren herstellung und deren anwendungen
HUP0002404A2 (hu) Aminosavszármazékok, hatóanyagként ezeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
ATE370127T1 (de) Pyrimidinische azyklonukleoside, verfahren zur ihrer herstellung und ihre verwendung
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
DE60225031D1 (de) Harnstoffoligomere, deren zusammensetzungen und verfahren zur deren herstellung
BRPI0409069A (pt) compostos quìmicos
CY1112050T1 (el) Νεα 2-αλογονοποιημενα παραγωγα της 5-0- δεσοσαμινυλερυθρονολιδης α, η διαδικασια της παρασκευης τους και η εφαρμογη τους ως φαρμακευτικα προϊοντα
ATE135681T1 (de) Diclofenac-cholinsalz, verfahren zur herstellung und pharmazeutische zusammensetzungen, die es enthalten
ATE325159T1 (de) Verfahren zur herstellung von synergistischen stabilisatorgemischen
EP1338596A4 (de) Verfahren zur herstellung antibakterieller verbindungen vom carbapenem-typ
DE60325631D1 (de) Verfahren zur herstellung von 2,6-dihalo-para-trifluoromethylanilin
ATE267832T1 (de) Substanz gm-95, verfahren zu ihrer herstellung und ihre verwendung
FI954786A0 (fi) Menetelmä aminometaanifosfonihapon valmistamiseksi
ATE211731T1 (de) Verfahren zur herstellung von aminophenylsulfonylharnstoffen und zwischenprodukte zu den verfahren
DE602005022345D1 (de) Eine phosphorylcholingruppe enthaltende verbindung, und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties